1. 20 SOMATIC MUTATIONAL MODEL TO PREDICT RESPONSE TO HYPOMETHYLATING AGENTS IN MYELODYSPLASTIC SYNDROMES. (April 2015) Authors: Nazha, A.; Radivoyevitch, T.; Thota, S.; Makishima, H.; Patel, B.; Seastone, D.; Carraway, H.; Carew, J.; Przychodzen, B.; Kalaycio, M.; Sekeres, M.; Maciejewski, J. Journal: Leukemia research Issue: Volume 39(2015:Apr.) Supplement 1 Page Start: S9 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. 310 RISK OF BONE MARROW FAILURE CONDITIONS IN PATIENTS UNDERGOING INVASIVE CARDIAC PROCEDURES. Issue 1 (April 2015) Authors: Ornstein, M.C.; Mukherjee, S.; Elson, P.; Pierce, C.; Zarzour, A.; Saunthararajah, Y.; Maggiotto, A.; Hobson, S.; Advani, A.S.; Gerds, A.T.; Carraway, H.; Kalaycio, M.; Maciejewski, J.P.; Ellis, S.; Blackstone, E.; Sekeres, M.A. Journal: Leukemia research Issue: Volume 39:Issue 1(2015:Jan.) Page Start: S154 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. 79 RISK OF MYELODYSPLASTIC SYNDROMES IN WELL-DIFFERENTIATED THYROID CANCERS TREATED WITH RADIOACTIVE IODINE. (April 2015) Authors: Pleyer, C.; Sidana, S.; Erik, O.; Radivoyevitch, T.; Advani, A.S.; Gerds, A.T.; Carraway, H.; Kalaycio, M.; Maciejewski, J.P.; Sekeres, M.A.; Mukherjee, S. Journal: Leukemia research Issue: Volume 39(2015:Apr.) Supplement 1 Page Start: S38 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Dissectioning Risk Factors for Myelodysplastic Syndrome (MDS) and Acute Myeloid Leukemia (AML) after Autotransplants for Plasma Cell Myeloma and Lymphomas. (April 2017) Authors: Hashmi, S.; Dean, R.M.; Shaw, B.; Brazauskas, R.; Millard, H.; Battiwalla, M.; Savani, B.; Flowers, M.E.; Cooke, K.R.; Hamilton, B.K.; Kalaycio, M.; Radivoyevitch, T.; Litzow, M.R.; Gale, R.P. Journal: Leukemia research Issue: Volume 55(2017)Supplement 1 Page Start: S41 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Increased Risk of Developing Myeloid Neoplasms, Including Myelodysplastic Syndrome, in Well-Differentiated Thyroid Cancers Treated with Radioactive Iodine. (April 2017) Authors: Molenaar, R.; Pleyer, C.; Radivoyevitch, T.; Carraway, H.; Kalaycio, M.; Maciejewski, J.; Sekeres, M.; Mukherjee, S. Journal: Leukemia research Issue: Volume 55(2017)Supplement 1 Page Start: S87 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗